GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Central Pharmaceutical JSC No2 (HSTC:DP2) » Definitions » Enterprise Value

Central Pharmaceutical JSC No2 (HSTC:DP2) Enterprise Value : ₫0.00 Mil (As of Jun. 10, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Central Pharmaceutical JSC No2 Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Central Pharmaceutical JSC No2's Enterprise Value is ₫0.00 Mil. Central Pharmaceutical JSC No2 does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Central Pharmaceutical JSC No2's EV-to-EBIT at this moment.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Central Pharmaceutical JSC No2's Enterprise Value is ₫0.00 Mil. Central Pharmaceutical JSC No2 does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Central Pharmaceutical JSC No2's EV-to-EBITDA at this moment.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Central Pharmaceutical JSC No2's Enterprise Value is ₫0.00 Mil. Central Pharmaceutical JSC No2 does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Central Pharmaceutical JSC No2's EV-to-Revenue at this moment.


Central Pharmaceutical JSC No2 Enterprise Value Historical Data

The historical data trend for Central Pharmaceutical JSC No2's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceutical JSC No2 Enterprise Value Chart

Central Pharmaceutical JSC No2 Annual Data
Trend
Enterprise Value

Central Pharmaceutical JSC No2 Semi-Annual Data
Enterprise Value

Competitive Comparison of Central Pharmaceutical JSC No2's Enterprise Value

For the Pharmaceutical Retailers subindustry, Central Pharmaceutical JSC No2's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Central Pharmaceutical JSC No2's Enterprise Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Central Pharmaceutical JSC No2's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Central Pharmaceutical JSC No2's Enterprise Value falls into.



Central Pharmaceutical JSC No2 Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Central Pharmaceutical JSC No2's Enterprise Value for the fiscal year that ended in . 20 is calculated as

Central Pharmaceutical JSC No2's Enterprise Value for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Central Pharmaceutical JSC No2  (HSTC:DP2) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.


Central Pharmaceutical JSC No2 Enterprise Value Related Terms

Thank you for viewing the detailed overview of Central Pharmaceutical JSC No2's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Central Pharmaceutical JSC No2 (HSTC:DP2) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 9 Tran Thanh Tong, Bach Dang Ward, Hai Ba Trung District, Hanoi, VNM
Central Pharmaceutical JSC No2 is engaged in the Trading of medicinal materials, pharmaceutical materials, chemicals, essential oils, modern medicines, traditional medicine drugs, cosmetics, and nutritious foods. Some of its products include Gentamycin injection solution 80; Genatreson Skin Cream; Ferimax Hard Capsules and others.

Central Pharmaceutical JSC No2 (HSTC:DP2) Headlines

No Headlines